Breakpoints
Breakpoints

Breakpoints

Society of Infectious Diseases Pharmacists

Overview
Episodes

Details

The SIDP Podcast

Recent Episodes

#136 – GAS, Streptococcus pyogenes: Call It What You Want, It’s Got a Big Reputation
JUN 5, 2026
#136 – GAS, Streptococcus pyogenes: Call It What You Want, It’s Got a Big Reputation
<p>Group A Streptococcal infections remain a global challenge, spanning common conditions like pharyngitis to severe invasive disease. Dr. Shiranee Sriskandan, Dr. Josh Osowicki, and Dr. Tom Parks join host Dr. Erin McCreary to explore the evolving landscape of Group A Strep. From unpacking vaccine development challenges and the ongoing burden of rheumatic fever, to rethinking durations of therapy for strep throat and the role of adjunctive treatments, we have you covered! Join us as we break down key controversies, share expert insights, and highlight practical pearls you can apply in your own practice.</p> <p>References: </p> <p>1. <a href="https://www.lancefieldsociety.org/" rel="nofollow">https://www.lancefieldsociety.org/</a> </p> <p>2. Osowicki J, Lamagni TL. Invasive Group A Streptococcal Disease in the US. <em>JAMA</em>. 2025;333(17):1493-1494. doi:10.1001/jama.2025.3257</p> <p>3. Davis K, Abo YN, Steer AC, Osowicki J. Chains of misery: surging invasive group A streptococcal disease. Curr Opin Infect Dis. 2024;37(6):485-493. doi:10.1097/QCO.0000000000001064</p> <p>4. Osowicki J, Azzopardi KI, Fabri L, et al. A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study. Lancet Microbe. 2021;2(7):e291-e299. doi:10.1016/S2666-5247(20)30240-8</p> <p>5. Hla TK, Osowicki J, Marsh JA, et al. Establishing the lowest penicillin concentration to prevent pharyngitis due to Streptococcus pyogenes using a human challenge model (CHIPS): a randomised, double-blind, placebo-controlled trial. <em>Lancet Microbe</em>. 2025;6(5):101038. doi:10.1016/j.lanmic.2024.101038</p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
play-circle icon
85 MIN
#135 – Stewie Struggles: Small Hospital Edition
MAY 22, 2026
#135 – Stewie Struggles: Small Hospital Edition
<p>Small hospitals bring unique stewardship challenges, but also unique opportunities. Dr. Tina Khadem and Dr. Ashley Cubillos join host Dr. Whitney Buckel to discuss the realities of antimicrobial stewardship in small and critical access hospitals. From navigating competing priorities and limited resources, to building strong provider relationships in close-knit communities, we have you covered! Join us as we unpack real-world strategies, challenge common perceptions, and highlight the practical pearls you can apply in your own setting.</p> <p><strong>References:</strong> </p> <ol> <li>Implementation of Core Elements at Small and Critical Access Hospitals: <a href="https://urldefense.com/v3/__https://www.cdc.gov/antibiotic-use/media/pdfs/core-elements-small-critical-508.pdf__;!!HnyL5y5g8FOd9kGaVA!DvOIRkUbmbnmm2SUz4NA6J4cyCOAZj1Ry4ZBnCVrE1bU-3IBgk6UcOCKJ4qlgTohnaw4d7lWnsWeBSqUjO2Gm0DkYgzwK9Km0rwB$ &quot;https://urldefense.com/v3/__https://www.cdc.gov/antibiotic-use/media/pdfs/core-elements-small-critical-508.pdf__;!!HnyL5y5g8FOd9kGaVA!DvOIRkUbmbnmm2SUz4NA6J4cyCOAZj1Ry4ZBnCVrE1bU-3IBgk6UcOCKJ4qlgTohnaw4d7lWnsWeBSqUjO2Gm0DkYgzwK9Km0rwB$&quot;" rel="nofollow">https://www.cdc.gov/antibiotic-use/media/pdfs/core-elements-small-critical-508.pdf</a></li> <li>Stenehjem E, Hyun DY, Septimus E, Yu KC, Meyer M, Raj D, Srinivasan A. Antibiotic Stewardship in Small Hospitals: Barriers and Potential Solutions. Clin Infect Dis. 2017 Aug 15;65(4):691-696.</li> <li>Veillette JJ, May SS, Gabrellas AD, Gelman SS, Albritton J, Lyons MD, Stenehjem EA, Webb BJ, Dalto JD, Throneberry SK, Stanfield V, Grisel NA, Vento TJ. A Fully Integrated Infectious Diseases and Antimicrobial Stewardship Telehealth Service Improves <em>Staphylococcus aureus</em> Bacteremia Bundle Adherence and Outcomes in 16 Small Community Hospitals. Open Forum Infect Dis. 2022 Oct 14;9(11):ofac549.</li> <li>Cubillos AL, Fortier K, Hoang A. P-920. Impact of Positive Blood Culture Antimicrobial Stewardship on Staphylococcus aureus Bloodstream Infection Management across Critical Access, Small, and Medium Community Hospitals. Open Forum Infect Dis. 2026 Jan 11;13(Suppl 1):ofaf695.1126.</li> <li>Smith LM, Ahern JW. Establishing Antibiotic Stewardship Programs in Rural Hospitals to Decrease Fluoroquinolone Prescribing: The Vermont Experience. Infect Prev Pract. 2021 Jan 21;3(1):100121.</li> <li>Kassamali-Escobar Z, et al. Antimicrob Steward Healthc Epidemiol 2024. doi: 10.1017/ash.2024.458. Imlay H, Ciarkowski CE, Bryson-Cahn C, et al Infect Control Hosp Epidemiol 2025. 46: 150–155, doi: 10.1017/ice.2024.206</li> <li>Ciarkowski CE, Imlay HN, Bryson-Cahn C, et al. Infect Control Hosp Epidemiol 2025. 46: 143–149, doi: 10.1017/ice.2024.171</li> <li>Stenehjem E, et al. JAMA Netw Open. 2023;6(5):e2313011. doi:10.1001/jamanetworkopen.2023.13011</li> </ol> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
play-circle icon
62 MIN
#134 – ESCMID Global Trials: PETER PEN and ASTARTE
MAY 8, 2026
#134 – ESCMID Global Trials: PETER PEN and ASTARTE
<p>Professor Mical Paul and Professor Jesús Rodríguez-Baño join Professor Josh Davis and Dr Erin McCreary for a special Breakpoints and Communicable podcast collaboration. This episode discusses the ‘Trials Run’ session at ESCMID Global, where two randomized, clinical trials are presented in great depth. This year, both trials focused on treatment of cephalosporin-resistant Enterobacterales bacteremia. Listen to the authors describe why they performed these trials, results, and implications for clinical practice.</p> <p>References:</p> <p>1.      Paul, M., &amp; Rodríguez-Baño, J. (2026, April 20). <em>The trial run: treatment of ESBL bacteraemia</em>[LW1]  <em>- off to never-never land</em>. [Presentation]. ESCMID Global 2026, Munich, Germany. <a href="https://www.google.com/url?sa=i\&amp;source=web\&amp;rct=j\&amp;url=https://www.escmid.org/congress-events/escmid-global/\&amp;ved=2ahUKEwilq56d15-UAxVukYkEHValMGAQy_kOegYIAQgHEAE\&amp;opi=89978449\&amp;cd\&amp;psig=AOvVaw2h4KK1dj0m0Zs4RvVuGxK3\&amp;ust=1777985757651000" rel="nofollow">ESCMID Global Virtual Platform</a>.</p> <p>2.      Bitterman R, Koppel F, Mussini C, et al. Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen). <em>BMJ Open</em>. 2021;11(2):e040210. Published 2021 Feb 8. doi:10.1136/bmjopen-2020-040210</p> <p>3.      Marín-Candón A, Rosso-Fernández CM, Bustos de Godoy N, et al. Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial [Internet]. BMJ Open. 2021 Sep 27;11(9):e049481. Available from: <a href="http://bmj.com" rel="nofollow">bmj.com</a> doi: 10.1136/bmjopen-2021-049481</p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
play-circle icon
63 MIN
#133 – Trash talk: Earth Day Special on Healthcare Sustainability and Stewardship
APR 17, 2026
#133 – Trash talk: Earth Day Special on Healthcare Sustainability and Stewardship
<p>Climate change in the context of healthcare can feel overwhelming but it doesn’t have to be paralyzing. We’re diving into the intersection of climate change and antimicrobial resistance with a focus on practical, actionable steps healthcare organizations can take.   Drs. Shreya Doshi, Andrea Pallotta and Preeti Jaggi join Dr. Whitney Buckel to talk about what’s real, what matters for healthcare, and where stewardship teams can make a meaningful impact.</p> <p>References:</p> <p>1.       Sustainabil‑ID. <a href="https://sustainabil-id.com/" rel="nofollow">https://sustainabil-id.com/</a></p> <p>2.       National Academy of Medicine. Climate Collaborative.https://<a href="http://nam.edu/our-work/programs/climate-and-health/climate-collaborative/" rel="nofollow">nam.edu/our-work/programs/climate-and-health/climate-collaborative/</a></p> <p>3.       Medicine for a Changing Planet. <a href="https://www.medicineforachangingplanet.org" rel="nofollow">https://www.medicineforachangingplanet.org</a></p> <p>4.       Cascades Canada. <a href="https://cascadescanada.ca/" rel="nofollow">https://cascadescanada.ca/</a></p> <p>5.       EcoRxChoice. <a href="https://ecorxchoice.com" rel="nofollow">https://ecorxchoice.com</a></p> <p>6.       Rx for Climate. <a href="https://www.rxforclimate.org/" rel="nofollow">https://www.rxforclimate.org/</a></p> <p>7.       Practice Greenhealth. <a href="https://practicegreenhealth.org" rel="nofollow">https://practicegreenhealth.org</a></p> <p>8.       Healthcare Without Harm. <a href="https://healthcarewithoutharm.org" rel="nofollow">https://healthcarewithoutharm.org</a></p> <p>9.       Healthcare Sustainability and Infectious Diseases. _J Pediatric Infect Dis Soc._https://<a href="http://academic.oup.com/jpids/pages/healthcare-sustainability-and-infectious-diseases" rel="nofollow">academic.oup.com/jpids/pages/healthcare-sustainability-and-infectious-diseases</a></p> <p>10.    PubMed. PMID: 40434281. <a href="https://pubmed.ncbi.nlm.nih.gov/40434281/" rel="nofollow">https://pubmed.ncbi.nlm.nih.gov/40434281/</a></p> <p>11.    PubMed Central. PMC12616928. <a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12616928/" rel="nofollow">https://pmc.ncbi.nlm.nih.gov/articles/PMC12616928/</a></p> <p>12.    Sustainable Healthcare Networks. Scale and spread quality improvement initiative promoting metronidazole IV‑to‑oral switch.https://<a href="http://networks.sustainablehealthcare.org.uk/resources/scale-and-spread-quality-improvement-initiative-promoting-metronidazole-iv-oral-switch-" rel="nofollow">networks.sustainablehealthcare.org.uk/resources/scale-and-spread-quality-improvement-initiative-promoting-metronidazole-iv-oral-switch-</a></p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
play-circle icon
48 MIN
#132 – Complicated UTIs: What’s Crystal Clear & What’s Still Cloudy
MAR 13, 2026
#132 – Complicated UTIs: What’s Crystal Clear & What’s Still Cloudy
<h1>Episode Notes</h1> <p>Complicated UTIs just got a whole lot less complicated—or did they? Dr. Dana Bowers and Kyle Molina (@kcmolinaID) join Dr. Whitney Buckel to break down what’s new, what’s controversial, and what this means for your day‑to‑day antimicrobial decisions. Join us as we dig into the biggest updates, the evidence behind them, and the clinical pearls you won’t want to miss.</p> <p>References:</p> <p>Nelson Z, Aslan AT, Beahm NP, et al. Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections in Pediatrics and Adults: A WikiGuidelines Group Consensus Statement. JAMA Netw Open. 2024 Nov 4;7(11):e2444495.</p> <p>Trautner BW, Cortes-Penfield NW, Gupta K, et al. Complicated Urinary Tract Infections (cUTI): Clinical Guidelines for Treatment and Management. Published July 17, 2025. <a href="https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/" rel="nofollow">https://www.idsociety.org/practice-guideline/complicated-urinary-tract-infections/</a></p> <p>Kadry N, Natarajan M, Bein E, Kim P, Farley J. Discordant Clinical and Microbiological Outcomes Are Associated With Late Clinical Relapse in Clinical Trials for Complicated Urinary Tract Infections. Clin Infect Dis 2023;76(10:1768-1775. <a href="https://academic.oup.com/cid/article/76/10/1768/6980780" rel="nofollow">https://academic.oup.com/cid/article/76/10/1768/6980780</a></p> <p>USCAST Oral cephalosporin STIC against S. aureus and E. coli meeting recording. <a href="https://www.youtube.com/watch?v=HieaVFAC08s" rel="nofollow">https://www.youtube.com/watch?v=HieaVFAC08s</a></p> <p>MacDougall C. A Cloudy Crystal Ball: Critically Assessing and Rethinking the Antibiogram. Clin Infect Dis. 2023;77(11):1501-1503. doi:10.1093/cid/ciad468</p> <p>Koehl J, Spolsdoff D, Negaard B, et al. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study. Ann Emerg Med. 2025;85(3):240-248. doi:10.1016/j.annemergmed.2024.10.013</p> <p>Dunne MW, Aronin SI, Das AF, et al. Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial. Clin Infect Dis. 2023;76(1):78-88. doi:10.1093/cid/ciac704</p> <p>Learn more about the Society of Infectious Diseases Pharmacists: <a href="https://protect2.fireeye.com/v1/url?k=4063f96c-1ff8c1be-4063b7ad-867b1e11f55a-4ebd02e8eaa2fcc2\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fsidp.org%2FAbout" rel="nofollow">https://sidp.org/About</a></p> <p>Instagram: @SIDPharm (<a href="https://www.instagram.com/sidpharm/" rel="nofollow">https://www.instagram.com/sidpharm/</a>) or @breakpointspodcast_sidp (<a href="https://www.instagram.com/breakpointspodcast_sidp/" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/</a>)<a href="https://www.instagram.com/breakpointspodcast_sidp/?hl=en" rel="nofollow">https://www.instagram.com/breakpointspodcast_sidp/?hl=en</a></p> <p>Facebook: <a href="https://protect2.fireeye.com/v1/url?k=55e28658-0a79be8a-55e2c899-867b1e11f55a-8b838b5b24786aee\&amp;q=1\&amp;e=caf63b63-0143-4fa9-a81b-8d3031af3116\&amp;u=https%3A%2F%2Fwww.facebook.com%2Fsidprx" rel="nofollow">https://www.facebook.com/sidprx</a></p> <p>LinkedIn: <a href="https://www.linkedin.com/company/sidp/" rel="nofollow">https://www.linkedin.com/company/sidp/</a></p> <p>SIDP welcomes pharmacists and non-pharmacist members with an interest in infectious diseases, learn how to join here: <a href="https://sidp.org/Become-a-Member" rel="nofollow">https://sidp.org/Become-a-Member</a></p> <p>Listen to Breakpoints on <a href="https://clicktime.symantec.com/3R8uEM1294vdh21uL7nDhi37VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DD0L0Q0-2A2f7TCFxVOgWn67jW1UJdXCNI8Kg8JiVOalanWSnv86s3-2A2feIgSCp0yFQqON7208n7OVg3dZANuq14i1FyBxNlUE-2A2fEuorj-2A2bQth-2A2f-2A2fdOz0-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJP8qJ0DM-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnaJ94CqlnGko8PYcHx7P0a2ORkqJjTTXTXo3of9toOI%26e%3D" rel="nofollow">iTunes</a>, <a href="https://clicktime.symantec.com/3UPSKiX9zWTmFRi5JvbYYuF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DuVw7WrCV3UsT9jQEoMx19bCJk8wSnOrHKsz-2A2fiDg5jIJz-2A2fPmlAAnjeQMczcZNKe65FwcZB1GSntOoUYpImtNgtdyfUUiYEctoWEc5okmtqjI-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJSsDRBjw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DiSHbkOT6yU9AfKVXVzZYoT6ihqn4rV7u2MtsJu0S4M0%26e%3D" rel="nofollow">Overcast</a>, <a href="https://clicktime.symantec.com/3PoPyJU9wVY1CeG5JSoJ5TF7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3D-2A2b6F4mrvzRMOPk-2A2ba-2A2bOlEsgbBTfXcxd55wOs9FeTrvlo4ldPpqgt3wD8-2A2fE3HTFftwPVPPM-2A2b6cPP8AXhMlUJL-2A2fVJcCllOYuUjVjRDDAWZ7AIEA-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJznOuBy8-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D2k6k5CxoFMUsUIyOPzQO6SsDBdBx1NhRPK1AYDToK7g%26e%3D" rel="nofollow">Spotify</a>, <a href="https://clicktime.symantec.com/3EzDPdcsg2aGkG24TqSDnQD7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DSMv1IUOMa6BBtA9x3UJdt0xL08TAUa63rcUQgIHTRk5z0skO9IEnaSqnkGdDVELU4LHF4xYo6n4QprSv5REh8CiWi24tVPHxui-2A2fuqe-2A2bSTcY-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgDogjBg-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dg4LAADo6MhO--d9qoDcdunhQOKfhr7JZ5QH6liBGX1w%26e%3D" rel="nofollow">Listen Notes</a>, <a href="https://clicktime.symantec.com/3K5DQtmVxCMwmFfYTXFqors7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DVTJG9hRIZySdc5y4-2A2bhe4mxglJA6g9BcwePDuINOrGkp6xW-2A2brG3A2kq5lxBfriwS6WTOLOSeS4ISBSaSBKW5soT53zrLCvjBMOj4J11xQuOQ-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgJndlwc-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3D8zQ_WQmmq_ADO_yxCG2pCmfPHOXyBOt3Tvd8SLzw0ZM%26e%3D" rel="nofollow">Player FM</a>, <a href="https://clicktime.symantec.com/3WCdXn4P2EkTbSZz3j2efpW7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DRuxN50dhXQmkw9mJ-2A2fIv1BwOldEM8lu6wJn-2A2bp-2A2bFH1TNKc-2A2fH8BYSR8y8gvYx02jfY5q57aOItrIB31hBXqNyioCeEXlh0uZxM-2A2b7yda7rBp-2A2bnQ-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJdwUkjek-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dph48oB1hX73YsIdjGLx2gcMvE6IA7KTEWazW2Gb_tGg%26e%3D" rel="nofollow">Pocket Casts</a>, <a href="https://clicktime.symantec.com/3N9YYH2wFKdrWqgcDLyAPVP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DbAcy2XwOPS5gzW3aqAHBDq3X-2A2fsXg3wyMXKklW6Ulzx0aRoyw2zdXn6m5fVIKUO608flwXYyAGXiN4hWz7mMsGMCS55chZ6PJz8V8gIyX8HI-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJgEBT6ts-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DPqs1eg6C2SkR8SgsjTAKF3jDx-0k2raeM9htByu_Ghs%26e%3D" rel="nofollow">Stitcher</a>, <a href="https://clicktime.symantec.com/3QxZKFTBT9VdfKHPUjpQykP7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DXRXFG9Dw8bLzFpLbMrEfM96UuBur0JW9QvgSd3FZ4RzNUy-2A2bAuHT4n48P5fT3624i4mKWOBMJ2c6glolIQP9Z0iI7LjIz87QyZ5cKKJCKaNc-2A3d-5F-5F-3BJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJErop2PU-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DM0gZOkT6pxtYnqMcQRd_VtlxUl-5PqROGqAmvy3qmMc%26e%3D" rel="nofollow">Google Play</a>, <a href="https://clicktime.symantec.com/3HAZ1dAKjokvr2fVP1FEFmZ7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DHM5q-2A2bqjVNHXHSuzhQfgDHnfYMTayJY5I54xK583XQlZuSY-2A2fiukAdy7bGkpDwwp4DsXAS8nTuZi2kow5ilRLCsjmfJitQC61ab1gmhUelJY4-2A3d-5F-5F-3BJSUl-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJpiKf8vY-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3Dl98Xj6atbJE3Bl9nQFR0NxeCSObWEBXn2QRprS9VAPM%26e%3D" rel="nofollow">TuneIn</a>, <a href="https://clicktime.symantec.com/3Uc5sj35HuHzBtN9qsZELaz7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DGDsckAp3VJZvS-2A2b-2A2bFQBnNnris8ulgVAn4tAgxp4bAnDy-2A2bDLqT7z-2A2btergfEsE7sz7-2A2fi9-2A2bFF54K4LSozTCeCmh8VOosKkqijPiN5VAKc79XwEk-2A3d-5F-5F-3BJSUlJSUlJQ-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJoMTwltw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DOqwdj1qqIUl3AHO7g0LP6TxXzSXeXUX4Ce_Sv_hRfyw%26e%3D" rel="nofollow">Blubrry</a>, <a href="https://clicktime.symantec.com/3Dfmv5CECYNRhGAwqZ5sQdY7VN?u=https%3A%2F%2Furldefense.proofpoint.com%2Fv2%2Furl%3Fu%3Dhttps-3A__urldefense.com_v3_-5F-5Fhttps-3A_sidp.org_EmailTracker_LinkTracker.ashx-3FlinkAndRecipientCode-3DQ7W-2A2bjxudl-2A2biTqflXrhVsrXi0r-2A2fptIhwKQytXBX17a9V2Op9GnTA1RTRGL19e54xgVdZSW-2A2bJeLiR7wWXkwDiSYgglUPHsNsGqAu6xuhXPp6o-2A3d-5F-5F-3BJSUlJSU-21-21NHLzug-21dngq5xycWCrDGial95M7tI5UvZ0hrj1je4zdNccDjhDKN5XA2UTqa18K5AmJzCo9rGw-2524%26d%3DDwMFaQ%26c%3DeuGZstcaTDllvimEN8b7jXrwqOf-v5A_CdpgnVfiiMM%26r%3DY8YtMys67u8RazcRiw-k49ag18dzD_0nTpHmfvVASdo%26m%3DXdaKjGMXuOKRQDNGYMG_peUNwKP87ezW6gBVWYRNwCs%26s%3DnBRVi03Hc0KelEEqohO2GHfC96p04Pkm8F2eHsswsZY%26e%3D" rel="nofollow">RadioPublic</a>, or by using our RSS feed: <a href="https://sidp.pinecast.co/" rel="nofollow">https://sidp.pinecast.co/</a></p>
play-circle icon
68 MIN